Pharma Reviews: Doklam effect? India said to block Fosun's $1.3 billion Gland purchase

India is poised to reject Shanghai Fosun Pharmaceutical Group Co's proposed $1.3 billion takeover of an Indian drugmaker, according to people ...
Read more: Doklam effect? India said to block Fosun's $1.3 billion Gland purchase